Surrey Heartlands

Joint Formulary & PAD

Somatropin - Growth failure - children

You are here : Home > Formulary Search > Somatropin - Growth failure - children

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
ICB
NICE
SPC
Restrictions / Comments :

Documentation

NICE Technology Appraisal
NICE TA188 - Somatropin for Growth Failure in Children
Evidence Review
Shared care and LCS review March 2026.docx

PAD Profile

ChemicalSubstance :
Somatropin
Indication :
Growth failure - children
Group Name :
Keywords :
Turner syndrome, growth hormone deficiency, born small for gestational age, short stature, Gonadal dysgenesis, shared care
Brand Names Include :
Genotropin, Norditropin FlexPro Omnitrope, Saizen, Zomacton
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Committee Recommendations (1)

28 Apr 26 - Surrey & Sussex Area Prescribing Committee (APC)

Agreement by Chair's Action to change the formulary Traffic Light Status from AMBER to BLUE.

Other Indications

Below are listed other indications that Somatropin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Growth failure - children.